Casey Cunningham

5.4k total citations
87 papers, 4.4k citations indexed

About

Casey Cunningham is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Casey Cunningham has authored 87 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 38 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in Casey Cunningham's work include Virus-based gene therapy research (15 papers), Cellular Mechanics and Interactions (11 papers) and CAR-T cell therapy research (10 papers). Casey Cunningham is often cited by papers focused on Virus-based gene therapy research (15 papers), Cellular Mechanics and Interactions (11 papers) and CAR-T cell therapy research (10 papers). Casey Cunningham collaborates with scholars based in United States, United Kingdom and Canada. Casey Cunningham's co-authors include John Nemunaitis, Thomas P. Stossel, David J. Kwiatkowski, John H. Hartwig, Neil Senzer, Paul A. Janmey, Jed B. Gorlin, H. Randolph Byers, Phillip B. Maples and Joseph A. Kuhn and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Casey Cunningham

87 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Casey Cunningham United States 33 2.2k 1.4k 1.1k 916 646 87 4.4k
John D. Lewis Canada 39 2.4k 1.1× 721 0.5× 528 0.5× 501 0.5× 302 0.5× 122 4.5k
Jody Rosenblatt United States 30 3.7k 1.7× 1.4k 1.0× 3.0k 2.7× 323 0.4× 531 0.8× 49 6.8k
Inger Helene Madshus Norway 34 2.8k 1.3× 845 0.6× 1.4k 1.3× 261 0.3× 729 1.1× 67 4.3k
Kaylene J. Simpson Australia 32 2.7k 1.2× 1.8k 1.3× 548 0.5× 657 0.7× 407 0.6× 110 4.7k
James B. Lorens Norway 38 3.1k 1.4× 1.6k 1.1× 511 0.5× 391 0.4× 1.6k 2.5× 141 5.7k
Mario Faretta Italy 24 3.0k 1.4× 845 0.6× 1.1k 1.1× 290 0.3× 254 0.4× 68 4.4k
Mark S. Dennis United States 36 2.7k 1.3× 854 0.6× 265 0.2× 463 0.5× 583 0.9× 54 4.9k
Yoav I. Henis Israel 49 5.3k 2.4× 862 0.6× 1.7k 1.6× 423 0.5× 468 0.7× 159 7.3k
Paule Opolon France 44 3.5k 1.6× 1.5k 1.1× 334 0.3× 1.3k 1.4× 1.1k 1.7× 159 6.6k
Rob C. Hoeben Netherlands 48 4.0k 1.8× 1.7k 1.2× 320 0.3× 3.8k 4.1× 1.3k 2.0× 208 7.6k

Countries citing papers authored by Casey Cunningham

Since Specialization
Citations

This map shows the geographic impact of Casey Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casey Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casey Cunningham more than expected).

Fields of papers citing papers by Casey Cunningham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casey Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casey Cunningham. The network helps show where Casey Cunningham may publish in the future.

Co-authorship network of co-authors of Casey Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Casey Cunningham. A scholar is included among the top collaborators of Casey Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casey Cunningham. Casey Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
FitzGerald, Nicholas, et al.. (2024). Immunization with an mRNA DTP vaccine protects against pertussis in rats. Infection and Immunity. 92(8). e0052023–e0052023. 3 indexed citations
2.
Wolf, M. Allison, Ting Y. Wong, William T. Witt, et al.. (2023). Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge. PLoS ONE. 18(11). e0286925–e0286925. 2 indexed citations
3.
Cunningham, Casey, Neil Senzer, Joe Stephenson, et al.. (2009). Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. BMC Cancer. 9(1). 263–263. 70 indexed citations
4.
Nemunaitis, John, Neil Senzer, Casey Cunningham, et al.. (2006). Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer. Molecular Therapy. 13(6). 1185–1191. 53 indexed citations
5.
Nemunaitis, John, Casey Cunningham, Neil Senzer, et al.. (2005). Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors. Cancer Investigation. 23(8). 671–676. 32 indexed citations
6.
McLoughlin, James M., Todd M. McCarty, Casey Cunningham, et al.. (2005). TNFerade, an Adenovector Carrying the Transgene for Human Tumor Necrosis Factor α, for Patients With Advanced Solid Tumors: Surgical Experience and Long-Term Follow-Up. Annals of Surgical Oncology. 12(10). 825–830. 44 indexed citations
7.
Nemunaitis, John, et al.. (2004). Phase I Trial of Topotecan in Combination with Gemcitabine in Refractory Solid Tumor Patients. Cancer Investigation. 22(3). 360–367. 3 indexed citations
8.
Cunningham, Casey, Sunil Chada, James A. Merritt, et al.. (2004). Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Molecular Therapy. 11(1). 149–159. 166 indexed citations
9.
Nemunaitis, John, Douglas Orr, Casey Cunningham, et al.. (2003). Phase I Study of Oral CI-994 in Combination with Gemcitabine in Treatment of Patients with Advanced Cancer. The Cancer Journal. 9(1). 58–66. 49 indexed citations
10.
Nemunaitis, John & Casey Cunningham. (2002). Emerging new therapies for chemotherapy—resistant cancer using adenoviral vectors. Drug Resistance Updates. 5(1). 34–46. 9 indexed citations
11.
Tong, Alex W., Yuan Zhang, Casey Cunningham, Phillip B. Maples, & John Nemunaitis. (2001). Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer. Clinical Lung Cancer. 2(3). 220–226. 8 indexed citations
12.
Furnish, Elizabeth J., Wei Zhou, Casey Cunningham, Josef A. Käs, & Christine E. Schmidt. (2001). Gelsolin overexpression enhances neurite outgrowth in PC12 cells. FEBS Letters. 508(2). 282–286. 26 indexed citations
13.
Nemunaitis, John, Neil Senzer, Casey Cunningham, & Thomas W. Dubensky. (2001). Virus-mediated killing of cells that lack p53 activity. Drug Resistance Updates. 4(5). 289–291. 9 indexed citations
14.
Cunningham, Casey, R. Vegners, Robert Bucki, et al.. (2001). Cell Permeant Polyphosphoinositide-binding Peptides That Block Cell Motility and Actin Assembly. Journal of Biological Chemistry. 276(46). 43390–43399. 97 indexed citations
15.
Nemunaitis, John, Casey Cunningham, Gerald M. Edelman, et al.. (2001). Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Therapy. 8(10). 746–759. 228 indexed citations
16.
17.
18.
Laine, Roney O., et al.. (1998). Gelsolin, a Protein That Caps the Barbed Ends and Severs Actin Filaments, Enhances the Actin-Based Motility of Listeria monocytogenes in Host Cells. Infection and Immunity. 66(8). 3775–3782. 26 indexed citations
19.
Martí, Amelia, Zhijun Luo, Casey Cunningham, et al.. (1997). Actin-biding Protein-280 Binds the Stress-activated Protein Kinase (SAPK) Activator SEK-1 and Is Required for Tumor Necrosis Factor-α Activation of SAPK in Melanoma Cells. Journal of Biological Chemistry. 272(5). 2620–2628. 144 indexed citations
20.
Prat, A. G., Eliezer J. Holtzman, Dennis Brown, et al.. (1996). Renal Epithelial Protein (Apx) Is an Actin Cytoskeleton-regulated Na+ Channel. Journal of Biological Chemistry. 271(30). 18045–18053. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John D. Lewis Breakdown of academic impact, for papers by Jody Rosenblatt Breakdown of academic impact, for papers by Inger Helene Madshus Breakdown of academic impact, for papers by Kaylene J. Simpson Breakdown of academic impact, for papers by James B. Lorens Breakdown of academic impact, for papers by Mario Faretta Breakdown of academic impact, for papers by Mark S. Dennis Breakdown of academic impact, for papers by Yoav I. Henis Breakdown of academic impact, for papers by Paule Opolon Breakdown of academic impact, for papers by Rob C. Hoeben
Rankless by CCL
2026